| Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ... Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005 | 803 | 2005 |
| Monoamine oxidase inactivation: from pathophysiology to therapeutics M Bortolato, K Chen, JC Shih Advanced drug delivery reviews 60 (13-14), 1527-1533, 2008 | 729 | 2008 |
| Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress M Bortolato, RA Mangieri, J Fu, JH Kim, O Arguello, A Duranti, A Tontini, ... Biological psychiatry 62 (10), 1103-1110, 2007 | 407 | 2007 |
| Anxiolytic-like properties of the anandamide transport inhibitor AM404 M Bortolato, P Campolongo, RA Mangieri, ML Scattoni, R Frau, V Trezza, ... Neuropsychopharmacology 31 (12), 2652-2659, 2006 | 261 | 2006 |
| Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates Z Justinova, RA Mangieri, M Bortolato, SI Chefer, AG Mukhin, JR Clapper, ... Biological psychiatry 64 (11), 930-937, 2008 | 178 | 2008 |
| Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence M Bortolato, JC Shih International review of neurobiology 100, 13-42, 2011 | 170 | 2011 |
| Novel monoamine oxidase A knock out mice with human-like spontaneous mutation AL Scott, M Bortolato, K Chen, JC Shih Neuroreport 19 (7), 739-743, 2008 | 169 | 2008 |
| Monoamine oxidase A and A/B knockout mice display autistic-like features M Bortolato, SC Godar, L Alzghoul, J Zhang, RD Darling, KL Simpson, ... International Journal of Neuropsychopharmacology 16 (4), 869-888, 2013 | 137 | 2013 |
| The role of monoamine oxidase A in aggression: Current translational developments and future challenges SC Godar, PJ Fite, KM McFarlin, M Bortolato Progress in neuro-psychopharmacology and biological psychiatry 69, 90-100, 2016 | 135 | 2016 |
| Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives S Tambaro, M Bortolato Recent Patents on CNS Drug Discovery (Discontinued) 7 (1), 25-40, 2012 | 129 | 2012 |
| The role of the serotonergic system at the interface of aggression and suicide M Bortolato, N Pivac, DM Seler, MN Perkovic, M Pessia, G Di Giovanni Neuroscience 236, 160-185, 2013 | 127 | 2013 |
| Accounting for the associations between child maltreatment and internalizing problems: The role of alexithymia S Brown, PJ Fite, K Stone, M Bortolato Child Abuse & Neglect 52, 20-28, 2016 | 124 | 2016 |
| Prenatal exposure to urban air nanoparticles in mice causes altered neuronal differentiation and depression-like responses DA Davis, M Bortolato, SC Godar, TK Sander, N Iwata, P Pakbin, JC Shih, ... PloS one 8 (5), e64128, 2013 | 123 | 2013 |
| Adverse effects of 5α-reductase inhibitors: what do we know, don’t know, and need to know? AM Traish, RC Melcangi, M Bortolato, LM Garcia-Segura, M Zitzmann Reviews in Endocrine and Metabolic Disorders 16, 177-198, 2015 | 112 | 2015 |
| Association of low-activity MAOA allelic variants with violent crime in incarcerated offenders DA Stetler, C Davis, K Leavitt, I Schriger, K Benson, S Bhakta, LC Wang, ... Journal of psychiatric research 58, 69-75, 2014 | 110 | 2014 |
| Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice M Bortolato, SC Godar, S Davarian, K Chen, JC Shih Neuropsychopharmacology 34 (13), 2746-2757, 2009 | 110 | 2009 |
| Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5, 8, 11, 14-tetraenamide] G La Rana, R Russo, P Campolongo, M Bortolato, RA Mangieri, V Cuomo, ... Journal of Pharmacology and Experimental Therapeutics 317 (3), 1365-1371, 2006 | 110 | 2006 |
| Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice M Bortolato, K Chen, SC Godar, G Chen, W Wu, I Rebrin, MR Farrell, ... Neuropsychopharmacology 36 (13), 2674-2688, 2011 | 108 | 2011 |
| Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders S Paba, R Frau, S C. Godar, P Devoto, F Marrosu, M Bortolato Current pharmaceutical design 17 (2), 151-167, 2011 | 107 | 2011 |
| Sex-dependent shared and nonshared genetic architecture across mood and psychotic disorders GAM Blokland, J Grove, CY Chen, C Cotsapas, S Tobet, R Handa, ... Biological psychiatry 91 (1), 102-117, 2022 | 106 | 2022 |
Jean C. Shih, Ph.D.University of Southern CaliforniaZweryfikowany adres z usc.edu
